Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Products for Immunology/Inflammation
- 5-Lipoxygenase(10)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(10)
- IκB/IKK(63)
- AP-1(3)
- KEAP1-Nrf2(63)
- NOD1(1)
- TLR(125)
- NF-κB(226)
- Interleukin Related(144)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(32)
- CD73(14)
- Complement System(51)
- Galectin(10)
- IFNAR(21)
- NO Synthase(73)
- NOD-like Receptor (NLR)(45)
- STING(97)
- Reactive Oxygen Species(436)
- Apoptosis(631)
- FKBP(19)
- eNOS(5)
- iNOS(28)
- nNOS(20)
- Glutathione(52)
- Adaptive Immunity(206)
- Allergy(125)
- Arthritis(32)
- Autoimmunity(175)
- Gastric Disease(91)
- Immunosuppressants(36)
- Immunotherapeutics(4)
- Innate Immunity(552)
- Pulmonary Diseases(110)
- Reactive Nitrogen Species(49)
- Reactive Sulfur Species(26)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- Cat.No. 产品名称 Information
- GC71405 ADS032 ADS032是NLRP1和NLRP3的双重抑制剂,可以快速、可逆和稳定地抑制炎性小体的形成。
- GC71396 Usnoflast Usnoflast是NLRP3调节剂以及非甾体抗炎药(NSAD)。
- GC71353 VU534 VU534是一种NAPE-PLD活化剂,EC50为0.30 μM。
- GC71351 HMGB1-IN-1 HMGB1-IN-1(化合物6)在RAW264.7细胞中显示出强烈的NO抑制作用,IC50值为15.9±0.6μM。
- GC71273 C12-TLRa C12-TLRa是一种辅助类脂。
- GC71259 NH2-C6-ARC186 sodium NH2-C6-ARC186 sodium是一种含有NH2-C6的改性ARC186,可以偶联到其他肽或分子。
- GC71258 ASK1-IN-4 ASK1-IN-4(化合物17)是ASK1抑制剂(IC50=0.2μM)。
- GC71232 I-152 I-152是含有n -乙酰半胱氨酸(NAC)和半胱胺(MEA)的缀合物。
- GC71230 NLRP3-IN-17 NLRP3-IN-17是一种有效的、选择性的、口服活性的NLRP3炎性小体抑制剂,IC50值为7 nM。
- GC71229 BMS905 BMS905是一种口服活性TLR7和TLR8双抑制剂(ic50分别为0.7和3.2 nM)。
- GC71215 TLR7 agonist 6 TLR7 agonist 6(化合物IIb-19)是一种TLR7激动剂,EC50值为1.0 nM。
- GC71189 STING-IN-5 STING-IN-5是一种强效的STING抑制剂,抑制LPS诱导的巨噬细胞中NO的合成,IC50值为1.15μM。
- GC71186 STING-IN-4 STING-IN-4(化合物1)是一种STING抑制剂,可抑制STING表达,从而减少STING和核因子-κB(NF-κB)信号传导的激活。
- GC71181 Glucocorticoid receptor modulator 1 Glucocorticoid receptor modulator 1是一种口服活性非甾体选择性糖皮质激素受体调节剂,对NF-κB和AP-1的IC50值分别为9 nM和130 nM。
- GC71149 NIC-0102 NIC-0102是一种口服活性蛋白酶体抑制剂(pIC50=7.55),其特异性抑制NLRP3炎性囊泡激活。
- GC71144 Phytoene desaturase-IN-1 Phytoene desaturase-IN-1是一种有效的八氢番茄红素脱饱和酶(PDS)抑制剂(Kd:65.9μM),通过与Phe301残基的π-π堆积效应。
- GC71137 ODN 24888 ODN 24888是鸟嘌呤修饰的抑制性寡核苷酸(INH-ODN)。
- GC71136 ODN 2395 sodium ODN 2395 sodium是一种C类寡脱氧核苷酸,可用作疫苗佐剂。
- GC71133 FITC-labeled ODN 1018 sodium FITC-labeled ODN 1018 sodium寡脱氧核苷酸是一种TLR-9激动剂。
- GC71129 Diprovocim-X Diprovocim-X(化合物35)是一种有效的TLR1/TLR2 (toll样受体1/2)激动剂,hTLR1/TLR2和mTLR1/TLR2的EC50值分别为0.14和0.75 nM。
- GC71128 Diclofenac-d4 sodium Diclofenac-d4 sodium是氘标记的双氯芬酸钠。
- GC71123 Galectin-8N-IN-1 Galectin-8N-IN-1(化合物19a)是一种强效且选择性的半乳凝素-8N抑制剂,Kd值为1.8μM。
- GC71119 UBX1325 UBX1325是一种促进衰老细胞凋亡的Bcl-xL抑制剂。
- GC71113 IL-2-IN-1 IL-2-IN-1是一种有效的IL-2抑制剂,IC50值为1978nM。
- GC71072 NXPZ-2 NXPZ-2是一种口服活性Keap1-Nrf2蛋白-蛋白相互作用(PPI)抑制剂,Ki值为95 nM,EC50值为120和170 nM。
- GC71071 Polyinosinic acid sodium Polyinosinic acid sodium是聚肌苷酸的钠形式。
- GC71031 Nrf2 activator-6 Nrf2 activator-6四氢异喹啉化合物是Nrf2活化剂。
- GC70987 Avacincaptad pegol sodium Avacincaptad pegol sodium是一种抗C5 RNA适配体,可抑制补体因子5 (C5)裂解为C5a和C5b。
- GC70979 Anti-inflammatory agent 38 Anti-inflammatory agent 38(化合物23d)是一种有效的Nrf2/HO-1途径抑制剂,对NO的IC50值为0.38 μM。
- GC70953 α7 nAchR-JAK2-STAT3 agonist 1 α7 nAchR-JAK2-STAT3 agonist 1是一种有效的α7 nAchR-JAK2-STAT3激动剂,对一氧化氮(NO)的IC50值为0.32 μM。
- GC70937 Paridiprubart Paridiprubart(NI-0101)是一种人源化的抗TLR4单克隆抗体。
- GC70900 TLR7/8 antagonist 2 TLR7/8 antagonist 2(化合物15)是TLR7/8的强效口服活性激动剂,IC50分别为4.9和0.6 nM。
- GC70868 Nrf2 activator-3 Nrf2 activator-3是一种有效的Nrf2激活剂。
- GC70853 Broussochalcone A Broussochalcone A是黄嘌呤氧化酶的抗氧化剂和抑制剂(IC50=2.21 μM),具有清除自由基的活性。
- GC70826 Guretolimod hydrochloride Guretolimod hydrochloride是Toll样受体7(TLR7)激动剂。
- GC70787 β-Aminoarteether β-Aminoarteether(SM934游离碱)是一种具有口服活性的青蒿素衍生物。
- GC70768 BMS-986251 BMS-986251是一种口服活性和选择性RORγt反向激动剂,RORγt-GAL4的EC50为12 nM。
- GC70759 AQX-435 AQX-435是一种强效的SHIP1磷酸酶激活剂。
- GC70756 Cytarabine-d2 Cytarabine-d2是氘标记的阿糖胞苷。
- GC70753 PDK4-IN-1 PDK4-IN-1是一种蒽醌衍生物和一种强效的口服活性丙酮酸脱氢酶激酶4(PDK4)抑制剂,IC50值为84nM。
- GC70742 Betamethasone-d5-1 βmethasone-d5-1氘标记为倍他米松。
- GC70733 ABT-510 acetate ABT-510 acetate是一种抗血管生成TSP肽(血小板反应蛋白-1类似物),在上皮性卵巢癌症原位同基因模型中诱导细胞凋亡并抑制卵巢肿瘤生长。
- GC70659 9-cis-Retinoic acid-d5 9-cis-Retinoic acid-d5是氘标记的9-顺式维甲酸。
- GC70612 Arochlor 1254 Arochlor 1254是一种多氯联苯(PCB)混合物,含有联苯和54%的氯。
- GC70584 Actinomycin X2 Actinomycin X2(放线菌素V),由许多链霉菌属产生。
- GC70571 CP-312 CP-312是一种强效的血红素加氧酶-1(HO-1)诱导剂。
- GC70570 RH01386 RH01386是一种小分子,可以预防内质网应激(ERS)诱导的β细胞功能障碍和死亡,并抑制促凋亡基因的表达。
- GC70567 NecroX-7 NecroX-7是一种强效的自由基清除剂和HMGB1(高迁移率族盒1)抑制剂。
- GC70520 MIND4-17 MIND4-17是一种强效的NRF2激活剂,共价修饰Keap1的C151残基。
- GC70485 Celiprolol-d9 hydrochloride Celiprolol-d9 hydrochloride是氘标记的盐酸塞利洛尔。